Eton Pharmaceuticals, Inc. (ETON) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $37.21M | +138.5% |
| 2024 | $15.60M | +47.4% |
| 2023 | $10.58M | +52.6% |
| 2022 | $6.93M | +145.2% |
| 2021 | $2.83M | +548.4% |
| 2020 | $436.0K | -3.8% |
| 2019 | $453.0K | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $37.21M | +138.5% |
| 2024 | $15.60M | +47.4% |
| 2023 | $10.58M | +52.6% |
| 2022 | $6.93M | +145.2% |
| 2021 | $2.83M | +548.4% |
| 2020 | $436.0K | -3.8% |
| 2019 | $453.0K | — |